Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Effects of Fucoidans from Five Different Brown Algae on Oxidative Stress and VEGF Interference in Ocular Cells.

Dörschmann P, Bittkau KS, Neupane S, Roider J, Alban S, Klettner A.

Mar Drugs. 2019 Apr 30;17(5). pii: E258. doi: 10.3390/md17050258.

2.

[Effect of Selective Retina Therapy (SRT) on the Inflammatory Microenvironment of the Subretinal Space].

Richert E, Bartsch S, Hillenkamp J, Treumer F, Tode J, von der Burchard C, Brinkmann R, Klettner AK, Roider J.

Klin Monbl Augenheilkd. 2019 May 2. doi: 10.1055/a-0838-5633. [Epub ahead of print] German.

PMID:
31049909
3.

Porcine RPE/Choroidal Explant Cultures.

Klettner A, Miura Y.

Methods Mol Biol. 2019;1834:109-118. doi: 10.1007/978-1-4939-8669-9_8.

PMID:
30324440
4.

Thermal Stimulation of the Retina Reduces Bruch's Membrane Thickness in Age Related Macular Degeneration Mouse Models.

Tode J, Richert E, Koinzer S, Klettner A, von der Burchard C, Brinkmann R, Lucius R, Roider J.

Transl Vis Sci Technol. 2018 May 1;7(3):2. doi: 10.1167/tvst.7.3.2. eCollection 2018 May.

5.

Release of Different Cell Mediators During Retinal Pigment Epithelium Regeneration Following Selective Retina Therapy.

Richert E, Koinzer S, Tode J, Schlott K, Brinkmann R, Hillenkamp J, Klettner A, Roider J.

Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1323-1331. doi: 10.1167/iovs.17-23163.

PMID:
29625455
6.

Long-term treatment with anti-VEGF does not induce cell aging in primary retinal pigment epithelium.

Schottler J, Randoll N, Lucius R, Caliebe A, Roider J, Klettner A.

Exp Eye Res. 2018 Jun;171:1-11. doi: 10.1016/j.exer.2018.03.002. Epub 2018 Mar 6.

PMID:
29522724
7.

Fucoidan Does Not Exert Anti-Tumorigenic Effects on Uveal Melanoma Cell Lines.

Dithmer M, Kirsch AM, Richert E, Fuchs S, Wang F, Schmidt H, Coupland SE, Roider J, Klettner A.

Mar Drugs. 2017 Jun 22;15(7). pii: E193. doi: 10.3390/md15070193.

8.

Ocular Trauma Score as prognostic value in traumatic ocular injuries due to rotating wire brushes.

Purtskhvanidze K, Rüfer F, Klettner A, Borzikowsky C, Roider J.

Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):1037-1042. doi: 10.1007/s00417-017-3629-6. Epub 2017 Mar 16.

PMID:
28303330
9.

Intravitreal injection of anti-Interleukin (IL)-6 antibody attenuates experimental autoimmune uveitis in mice.

Tode J, Richert E, Koinzer S, Klettner A, Pickhinke U, Garbers C, Rose-John S, Nölle B, Roider J.

Cytokine. 2017 Aug;96:8-15. doi: 10.1016/j.cyto.2017.02.023. Epub 2017 Mar 6.

PMID:
28267649
10.

Reduction of GAPDH in lenses of Parkinson's disease patients: A possible new biomarker.

Klettner A, Tholey A, Wiegandt A, Richert E, Nölle B, Deuschl G, Roider J, Schneider SA.

Mov Disord. 2017 Mar;32(3):459-462. doi: 10.1002/mds.26863. Epub 2016 Nov 10.

PMID:
27859598
11.

The Antiproliferative Effect of Bevacizumab on Human Tenon Fibroblasts Is Not Mediated by Vascular Endothelial Growth Factor Inhibition.

Fischer CV, Mans V, Horn M, Naxer S, Klettner A, van Oterendorp C.

Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4970-4977. doi: 10.1167/iovs.16-19938.

PMID:
27654424
12.

Alpha synuclein and crystallin expression in human lens in Parkinson's disease.

Klettner A, Richert E, Kuhlenbäumer G, Nölle B, Bhatia KP, Deuschl G, Roider J, Schneider SA.

Mov Disord. 2016 Apr;31(4):600-1. doi: 10.1002/mds.26557. Epub 2016 Feb 16. Review. No abstract available.

PMID:
26880170
13.

Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis.

Klettner A.

Mar Drugs. 2016 Feb 3;14(2). pii: E31. doi: 10.3390/md14020031. Review.

14.

The role of Fc-receptors in the uptake and transport of therapeutic antibodies in the retinal pigment epithelium.

Dithmer M, Hattermann K, Pomarius P, Aboul Naga SH, Meyer T, Mentlein R, Roider J, Klettner A.

Exp Eye Res. 2016 Apr;145:187-205. doi: 10.1016/j.exer.2015.12.013. Epub 2016 Jan 8.

PMID:
26773870
15.

Pre-Analytical Parameters Affecting Vascular Endothelial Growth Factor Measurement in Plasma: Identifying Confounders.

Walz JM, Boehringer D, Deissler HL, Faerber L, Goepfert JC, Heiduschka P, Kleeberger SM, Klettner A, Krohne TU, Schneiderhan-Marra N, Ziemssen F, Stahl A.

PLoS One. 2016 Jan 5;11(1):e0145375. doi: 10.1371/journal.pone.0145375. eCollection 2016.

16.

Effects of Cytokine Activation and Oxidative Stress on the Function of the Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells.

Juuti-Uusitalo K, Nieminen M, Treumer F, Ampuja M, Kallioniemi A, Klettner A, Skottman H.

Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6265-74. doi: 10.1167/iovs.15-17333. Erratum in: Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2263.

PMID:
26431480
17.

[Age-related macular degeneration - biology and treatment].

Klettner A.

Med Monatsschr Pharm. 2015 Jul;38(7):258-64; quiz 265-6. Review. German.

PMID:
26364363
18.

Basal and apical regulation of VEGF-A and placenta growth factor in the RPE/choroid and primary RPE.

Klettner A, Kaya L, Flach J, Lassen J, Treumer F, Roider J.

Mol Vis. 2015 Jul 10;21:736-48. eCollection 2015.

19.

Compatibility of recombinant tissue plasminogen activator (rtPA) and aflibercept or ranibizumab coapplied for neovascular age-related macular degeneration with submacular haemorrhage.

Klettner A, Grotelüschen S, Treumer F, Roider J, Hillenkamp J.

Br J Ophthalmol. 2015 Jun;99(6):864-9. doi: 10.1136/bjophthalmol-2014-306454. Epub 2015 Mar 4.

PMID:
25740806
20.

Intracellular pathways following uptake of bevacizumab in RPE cells.

Aboul Naga SH, Dithmer M, Chitadze G, Kabelitz D, Lucius R, Roider J, Klettner A.

Exp Eye Res. 2015 Feb;131:29-41. doi: 10.1016/j.exer.2014.12.010. Epub 2014 Dec 19.

PMID:
25533679

Supplemental Content

Loading ...
Support Center